AstraZeneca Buys Heart Firm Omthera for up to $443 Million

28.05.2013 - AstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain's second-biggest drugmaker. The...